This inventor holds 3 USPTO granted patents. Top assignee: University of Washington. Active years: 2008-2018.
Company Filing History:
Years Active: 2008-2018
Title: Jeff D Goldy: Innovator in Neurological Disease Research
Introduction
Jeff D Goldy is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of genetic research, particularly in understanding peripheral neurological diseases. With a total of 3 patents to his name, Goldy is recognized for his innovative approaches to identifying genetic mutations associated with Charcot-Marie-Tooth neuropathy type 1C.
Latest Patents
Goldy's latest patents focus on methods for identifying subjects susceptible to Charcot-Marie-Tooth neuropathy type 1C. One aspect of his invention provides methods for identifying genetic mutations linked to peripheral neurological disease. This involves comparing nucleic acid sequences of the SIMPLE gene from subjects exhibiting peripheral neuropathy to those who do not. The differences identified are genetic mutations associated with the disease. Additionally, his patents include isolated nucleic acid molecules encoding SIMPLE missense mutations and methods for screening subjects to determine their genetic predisposition to develop this type of neuropathy. Furthermore, he has developed kits for determining susceptibility or presence of Charcot-Marie-Tooth type 1C neuropathy in mammalian subjects.
Career Highlights
Goldy is affiliated with the University of Washington, where he conducts his research and develops his inventions. His work has been instrumental in advancing the understanding of genetic factors in neurological diseases.
Collaborations
Some of his notable coworkers include Phillip F Chance and Valerie A Street, who have collaborated with him on various research projects.
Conclusion
Jeff D Goldy is a key figure in the field of neurological disease research, with a focus on genetic mutations related to Charcot-Marie-Tooth neuropathy type 1C. His innovative patents and contributions to the University of Washington highlight his commitment to advancing medical science.